PATENT CLAIM ANALYSIS

Application Number: 15760660
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "130100"]

Abstract:
Methods of diagnosis and methods of treatment and prevention for autism spectrum disorder are provided using decoy antigens to maternal brain-reactive antibodies.

Claim (Index 18):
The method of  claim 1 , wherein the mother has been diagnosed as at risk for an autism spectrum disorder in her fetus by a method comprising obtaining a sample from the mother's blood and quantifying the level of antibody directed to Caspr2, KCNAB2, KCNAB1, EDIL3, IVD, SULT4A1, TNIP2, RAI16 or GDPD5 in the sample, and comparing the level so quantified to a predefined control level of the respective antibody, wherein an antibody level in the sample in excess of the control level has been determined, so diagnosing the mother as at risk for an autism spectrum disorder in her fetus.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.09524
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15042976', '12266814', '11381943', '15353037', '15136021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7052835023391162
- 35 USC 102 Novelty (BERT): 0.4911710252468548
- Combined Prediction Score: 0.6838722546298901
- Mean Citation Score: 172.780086
- Max Citation Score: 210.8995
- Similarity Product: 147.88258032286166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test